Viewing Study NCT05413018

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2026-06-10 @ 11:41 PM
Study NCT ID: NCT05413018
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-08
First Post: 2022-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Azacitidine View
None CC-486 View
None Onureg View
None Acute Myeloid Leukemia View